Irish Pharmaceutical Healthcare Association

EU Legislative Interests

The main focus of IPHA activities is targeted at European and Irish pharmaceutical legislation and policies. The main focus of our current activities in relation to European legislation and policy is the revision of the General Pharmaceutical Legislation, the Orphan Medicines Regulation and Regulation of Medicinal Products for Paediatric use, the proposed Critical Medicines Act and Biotech Act. We also work to see a re-evaluation of the Urban Waste Water Treatment Directive and focus on its transposition into domestic Irish Legislation and operation of Extender Producer Responsibility for our industry. We are keenly interested in competitiveness and health policies of the Union and as proposed and developed by the Commission. To understand policies and proposal and to put forward our Association's perspectives on them, we seek to meet member and officials of the European Commission and of the European Parliament, and national representatives at the Council of Ministers in various formations.

Communication Activities

Public information, conferences (online and in-person), meetings with MEPs, the European Commission and Ireland's Permanent Representation at to the EU and members of the Irish Government and officials involved in the Council of Ministers.

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

www.efpia.eu www.aesgp.eu www.ifpma.org

Organisation Members

as above

Additional Information

In 2022, we hired the public affairs consulting firm, Vulcan Consulting (https://vulcanconsulting.eu); 38/39 Baggot Street Lower, Dublin 2, D02 T938, Ireland) in relation to the activities described in Heading 9. We do not fully outsource this activity or our representation to the firm. They advise and work with us in carrying out that activity.